Attentional Control and Brain Metabolite Levels in Methamphetamine Abusers

Biological Psychiatry

Volumn 61, Issue 11, 2007, Pages 1272-1280

  Salo, Ruth ^a,b   Nordahl, Thomas E ^a,b   Natsuaki, Yutaka ^b,c   Leamon, Martin H ^a   Galloway, Gantt P ^d   Waters, Christy ^e   Moore, Charles D ^e   Buonocore, Michael H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of California   (United States)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

Anterior cingulate cortex; attention; imaging; methamphetamine; MRS; NAA; Stroop

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; METHAMPHETAMINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; ATTENTION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; VISUAL CORTEX;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTENTION; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOLINE; COGNITION; CREATINE; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SMOKING; VISUAL CORTEX;

EID: 34248228189     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.07.031     Document Type: Article

References (66)

1. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508 (1987) 333-348
2. Brody A.L., Olmstead R.E., London E.D., Farahi J., Meyer J.H., Grossman P., et al. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161 (2004) 1211-1218
3. Carter C.S., Botvinick M.M., and Cohen J.D. The contribution of the anterior cingulate cortex to executive processes in cognition. Rev Neurosci 10 (1999) 49-57
4. Cecil K.M., Lenkinski R.E., Meaney D.F., McIntosh T.K., and Smith D.H. High-field proton magnetic resonance spectroscopy of a swine model for axonal injury. J Neurochem 70 (1998) 2038-2044
5. Chambers R.A., Krystal J.H., and Self D.W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol Psychiatry 50 (2001) 71-83
6. Chang L., Ernst T., Poland R.E., and Jenden D.J. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. Life Sci 58 (1996) 2049-2056
7. Cohen G., Andreasen N.C., Alliger R., Arndt S., Kuan J., Yuh W.T.C., and Ehrhardt J. Segmentation techniques for the classification of brain tissue using MRI. Psychiatry Res 45 (1992) 33-51
8. Community Epidemiology Work Group. Epidemiologic Trends in Drug Abuse-Advance Report (2004), U.S. Department of Health and Human Services, National Institutes of Health, Bethesda, MD
9. Durazzo T.C., Gazdzinski S., Rothlind J.C., Banys P., and Meyerhoff D.J. Brain metabolite concentrations and neurocognition during short-term recovery from alcohol dependence: Preliminary evidence of the effects of concurrent chronic cigarette smoking. Alcohol Clin Exp Res 30 (2006) 539-551
10. Eberling J.L., Roberts J.A., Taylor S.E., VanBrocklin H.F., O'Neil J.P., and Nordahl T.E. Effects of age and estrogen on aromatic L-amino acid decarboxylase activity in rhesus monkey brain. Neurobiol Aging 23 (2002) 479-483
11. Ernst T., Chang L., Leonido-Yee M., and Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H-MRS study. Neurology 54 (2000) 1344-1349
12. First M.B., Spitzer L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (1995), Biometrics Research Department, New York State Psychiatric Institute, New York
13. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., et al. Inhibition of MAO B in the brains of smokers. Nature 379 (1996) 733-738
14. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., Shea C., et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proc Natl Acad Sci U S A 93 (1996) 14065-14069
15. Frederick B.D., Satlin A., Yurgelun-Todd D.A., and Renshaw P.F. In vivo proton magnetic resonance spectroscopy of Alzheimer's disease in the parietal and temporal lobes. Biol Psychiatry 42 (1997) 147-150
16. Gonen O., Catalaa I., Bann J.S., Ge Y., Mannon L.J., Kolson D.L., and Grossman R.I. Total brain N-acetylaspartate: A new measure of disease in MS. Neurology 54 (2000) 15-19
17. Grachev I.D., Kumar R., Ramachandran T.S., and Szeverenyi N.M. Cognitive interference is associated with neuronal marker N-acetyl aspartate in the anterior cingulate cortex: An in vivo (1)H-MRS study of the Stroop Color-Word task. Mol Psychiatry 6 (2001) 529-539
18. Hall H., Sedvall G., Magnusson O., Kopp J., Halldin C., and Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology 11 (1994) 245-256
19. Henik A., and Salo R. Schizophrenia and the Stroop effect. Behav Cogn Neurosci Rev 3 (2004) 42-59
20. Jentsch J.D., and Taylor J.R. Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 146 (1999) 373-390
21. Kalechstein A.D., Newton T.F., and Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. J Neuropsychiatry Clin Neurosci 15 (2003) 215-220
22. Kalivas P.W., and Volkow N.D. The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162 (2005) 1403-1413
23. Kattapong V.J., Brooks W.M., Wesley M.H., Kodituwakku P.W., and Rosenberg G.A. Proton magnetic resonance spectroscopy of vascular and Alzheimer-type dementia. Arch Neurol 53 (1996) 678-680
24. Kerns J.G., Cohen J.D., MacDonald III A.W., Cho R.Y., Stenger V.A., and Carter C.S. Anterior cingulate conflict monitoring and adjustments in control. Science 303 (2004) 1023-1026
25. Kornetsky C., Mirsky A.F., Kessler E.K., and Dorff J.E. The effects of d-amphetamine on behavioral deficits produced by sleep loss in humans. J Pharmacol 127 (1959) 46-50
26. Lim K.O., Adalsteinsson A., Spielman D., Rosenbloom M.J., Sullivan E.V., and Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry 55 (1998) 346-352
27. MacDonald III A.W., Cohen J.D., Stenger V.A., and Carter C.S. Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 288 (2000) 1835-1838
28. MacLeod C.M. Half a century of research on the Stroop effect: An integrative review. Psychol Bull 109 (1991) 163-203
29. Manji H.K., Moore G.J., Rajkowska G., and Chen G. Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5 (2000) 578-593
30. McKetin R., and Mattick R.P. Attention and memory in illicit amphetamine users: Comparison with non-drug-using controls. Drug Alcohol Depend 50 (1998) 181-184
31. Miller G., Gainet-Dinov R., Levey A., and Caron M. Dopamine transporters and neuronal injury. Trends Pharmacol Sci 10 (1999) 424-429
32. National Drug Intelligence Center. National Drug Threat Assessment (2005): Summary Report. Washington, DC: U.S. Department of Justice.
33. Nelson H.E. The National Adult Reading Test (NART) (1982), Nelson, Windsor, Canada
34. Nordahl T.E., Salo R., and Leamon M.H. Neuropsychological effects of methamphetamine use: A review. J Neuropsychiatry Clin Neurosci 15 (2003) 317-325
35. Nordahl T.E., Salo R., Natsuaki Y., Galloway G.P., Waters C., Moore C.D., et al. Methamphetamine users in sustained abstinence: A proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 62 (2005) 444-452
36. Nordahl T.E., Salo R., Possin K., Gibson D.R., Flynn N., Leamon M., et al. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: A preliminary proton MRS study. Magnetic resonance spectroscopy. Psychiatry Res 116 (2002) 43-52
37. Office of Applied Studies, Substance Abuse and Mental Health Services Administration (SAMHSA). The DASIS report: Primary methamphetamine/amphetamine treatment admissions: 1992-2002 (2004). Available at: http://www.oas.samhsa.gov/2k4/methTX/methTX.cfm. Accessed June 13, 2005.
38. Ohrmann P., Kersting A., Suslow T., Lalee-Mentzel J., Donges U., Fiebich M., et al. Proton magnetic resonance spectroscopy in anorexia nervosa: Correlations with cognition. Neuroreport 15 (2004) 549-553
39. Paulus M.P., Hozack N., Frank L., Brown G.G., and Schuckit M.A. Decision making by methamphetamine-dependent subjects is associated with error-rate independent decrease in prefrontal and parietal activation. Biol Psychiatry 53 (2003) 65-74
40. Paus T. Primate anterior cingulate cortex: Where motor control, drive and cognition interface. Nat Rev Neurosci 6 (2001) 417-424
41. Pennypacker K.R., Kassed C.A., Eidizadeh S., and O'Callaghan J.P. Brain injury: Prolonged induction of transcription factors. Acta Neurobiol Exp 60 (2000) 515-528
42. Pfefferbaum A., Adalsteinsson E., Spielman D., Sullivan E.V., and Lim K.O. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging. Magn Reson Med 41 (1999) 276-284
43. Pfefferbaum A., Sullivan E.V., Hedehus M., Lim K.O., Adalsteinsson E., and Moseley M. Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planer diffusion tensor imaging. Magn Reson Med 44 (2000) 259-268
44. Porrino L.J., and Lyons D. Orbital and medial prefrontal cortex and psychostimulant abuse: Studies in animal models. Cereb Cortex 10 (2000) 326-333
45. Ricaurte G.A., Guillery R.W., Seiden L.S., Schuster C.R., and Moore R.Y. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res 235 (1982) 93-103
46. Ricaurte G.A., Schuster C.R., and Seiden L.S. Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res 193 (1980) 153-163
47. Ricaurte G.A., Schuster C.R., and Seiden L.S. Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers. Brain Res 303 (1984) 359-364
48. Ricaurte G.A., Seiden L.S., and Schuster C.R. Increased dopamine metabolism in the rat neostriatum after toxic doses of d-methylamphetamine. Neuropharmacology 22 (1983) 1383-1388
49. Robbins T.W., and Everitt B.J. Drug addiction: Bad habits add up. Nature 398 (1999) 567-570
50. Rogers R.D., Everitt B.J., Baldacchino A., Blackshaw A.J., Swainson R., Wynne K., et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology 20 (1995) 322-339
51. Sager T.N., Topp S., Torup L., Hanson L.H., Egestad B., and Moller A. Evaluation of CA1 damage using single-voxel 1H-MRS and un-biased stereology: Can non-invasive measures of N-acetyl-aspartate following global ischemia be useful as a reliable measure of neuronal damage?. Brain Res 892 (2001) 166-175
52. Salo R., Nordahl T.E., Moore C., Waters C., Natsuaki Y., Galloway G.P., et al. A dissociation in attentional control: Evidence from methamphetamine dependence. Biol Psychiatry 57 (2005) 310-313
53. Salo R., Nordahl T.E., Possin K., Leamon M., Gibson D.R., Galloway G.P., et al. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res 111 (2002) 65-74
54. Seashore R.H., and Ivy A.C. Effects of analeptic drugs in relieving fatigue. Psychol Monogr 67 (1953) 1-16
55. Sim T., Simon S.L., Domier C.P., Richardson K., Rawson R.A., and Ling W. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology. J Addict Dis 21 (2002) 75-89
56. Simon S.L., Domier C., Carnell J., Brethren P., Rawson R., and Ling W. Cognitive impairment in individuals currently using methamphetamine. Am J Addict 9 (2000) 222-231
57. Simmons M.S., Frondoza C.G., and Coyle J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45 (1991) 37-45
58. Soetens E., Casaer S., D'Hooge R., and Hueting J.E. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology 119 (1995) 155-162
59. Stroop J.R. Studies of interference in serial verbal reactions. J Exp Psychol 18 (1935) 643-662
60. Taylor M.J., Alhassoon O.M., Schweinsburg B.C., Videen J.S., and Grant I. MR spectroscopy in HIV and stimulant dependence HNRC group. J Int Neuropsychol Soc 6 (2000) 83-85
61. Tedeschi G., Battalion A., Lundbom N., Bonavita S., Patronas N.J., Duyn J.H., et al. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 47 (1996) 696-704
62. Tsai G., and Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 46 (1995) 531-540
63. United Nations Office on Drugs and Crime. The world drug problem: A status report. 2004 World Drug Report Vol 1 (2004), United Nations, Vienna 25-56
64. Villemagne V., Yuan J., Wong D.F., Dannals R.F., Hatzidimitriou G., Mathews W.B., et al. Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [C-11]WIN-35,428 positron emission tomography studies and direct in vitro determinations. J Neurosci 18 (1998) 419-427
65. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158 (2001) 377-382
66. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., and Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181 (1980) 151-160